# Commission Decision of 30 March 2007 concerning a Community financial contribution towards a baseline survey on the prevalence of Salmonella in slaughter pigs to be carried out in Bulgaria and in Romania (notified under document number C(2007) 1394) (Only the Bulgarian and Romanian texts are authentic) (2007/219/EC), Division 4.5: Testing of anti-microbial susceptibility

Extent: E+W+S+N.I.

In the case of testing for anti-microbial susceptibility (optional), a validated and controlled method for testing shall be used, such as those recommended by the National Committee for Clinical Laboratory Standards (NCCLS, since 1st of January 2005: ‘Clinical and Laboratory Standards Institute’ — CLSI).
Both agar diffusion and broth dilution methods shall be acceptable. Results shall be reported both as quantitative data (MIC for dilution methods and inhibition zone diameter for diffusion methods) and as qualitative data (proportion resistant isolates).
Qualitative data shall be based on interpretation according to epidemiological cut-off values presented by the European Committee on Antimicrobial Susceptibility Testing (EUCAST) at: http://www.eucast.org
The isolates shall be tested for the susceptibility to the antimicrobial substances listed below:
Ampicillin or Amoxicillin
Tetracycline
Chloramphenicol
Florfenicol
Nalidixic acid
Ciprofloxacin (preferably) or Enrofloxacin
Sulphonamide (preferably Sulfametoxazole)
Sulphonamide/Trimethoprim or Trimethoprim
Gentamicin
Streptomycin
Kanamycin (preferably) or Neomycin
3rd generation cephalosporin, (preferably cefotaxime)
Colistin (optional)
Before initiation of the study the two Member States shall organise training for the involved parties.

---
Source: https://www.legislation.gov.uk/eudn/2007/219/annex/I/division/4/division/4.5 (the official version)
Page: https://openlegislation.uk/eu-decision-2007-219/annex-I/division-4/division-4.5
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.